Research progress on current pharmacokinetic evaluation of Chinese herbal medicines

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 5, 2011, Pages 644-649

  Li, Guofu ^a   Zhao, Haoru ^a   Yang, Jin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Biopharmaceutics drug disposition classification system; Herb drug interaction; Pharmacokinetic markers; Pharmacokinetics of Chinese herbal medicines; Statistical momen

Indexed keywords

HERBACEOUS AGENT;

CHINESE HERB; CHINESE MEDICINE; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; PHARMACOKINETICS; REVIEW;

ANIMALS; BIOMARKERS, PHARMACOLOGICAL; DRUGS, CHINESE HERBAL; HERB-DRUG INTERACTIONS; HERBAL MEDICINE; HUMANS;

EID: 79957580271     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20110526     Document Type: Review

References (28)

1. FDA. Guidance for Industry, Botanical drug products [S]. 2004.
2. Wu K M, Ghantous H, Bimkrant D. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States[J ]. Food Chem Toxicol, 2008,46(8):2606.
3. Yu Z, Gao X, Zhao Y, et al. HPLC determination of safflor yellow A and three active isoflavones from TCM Naodesheng in rat plasma and tissues and its application to pharmacokinetic studies[J]. Biomed Chromatogr, 2007,21(6):577.
4. Zhang L, Liu W, Zhang R, et al. Pharmacokinetic study of matrine, oxymatrine and oxysophocarpine in rat plasma after oral administration of Sophora flavescens Ait. extract by liquid chromatography tandem mass spectrometry [J]. J Pharm Biomed Anal, 2008,47(4/5):892.
5. Ma H, Wang Y, Guo T, et al. Simultaneous determination of tetrahydropalmatine, protopine, and palmatine in rat plasma by LC-ESI-MS and its application to a pharmacokinetic study [J]. J Pharm Biomed Anal, 2009,49(2):440.
6. Li X, Wang G, Sun J, et al. Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional Chinese medicine (TCM) in rats[J]. Biol Pharm Bull, 2007,30(5):847.
7. Guo X, Chen X, Li L, et al. LC-MS determination and pharmacokinetic study of six phenolic components in rat plasma after taking traditional Chinese medicinal-preparation: guanxinning lyophilized powder for injection[J]. J Chromatogr B, 2008,873(1): 51.
8. Zhang F, Tang M H, Chen L J, et al. Simultaneous quantitation of aconitine, mesaconitine, hypaconitine, benzoylaconine, benzoylmesaconine and benzoylhypaconine in human plasma by liquid chromatography-tandem mass spectrometry and pharmacokinetics evaluation of "SHEN-FU" injectable powder[J]. J Chromatogr B, 2008,873(2):173.
9. Wang Y, Yao Y, An R, et al. Simultaneous determination of puerarin, daidzein, baicalin, wogonoside and liquiritin of GegenQinlian decoction in rat plasma by ultra-performance liquid chromatography-mass spectrometry[J]. J Chromatogr B, 2009, 877 (20/21):1820.
10. Tang W F, Yu Q, Wan M H, et al. Simultaneous determination and pharmacokinetic studies of aloe emodin and chrysophanol in rats after oral administration of Da-Cheng-Qi decoction by high-performance liquid chromatography [J]. Biomed Chromatogr, 2007,21(7):701.
11. Xu F, Liu Y, Zhang Z, et al. Rapid simultaneous quantification of five active constituents in rat plasma by high-performance liquid chromatography/tandem mass spectrometry after oral administration of Da-Cheng-Qi decoction[J]. J Pharm Biomed Anal, 2008, 47(3):586.
12. Yu Q, Xiang J, Tang W, et al. Simultaneous determination of the 10 major components of Da-Cheng-Qi decoction in dog plasma by liquid chromatography tandem mass spectrometry[J]. J Chromatogr B, 2009,877(22):2025.
13. Lu T, Yang J, Gao X, et al. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine [J]. Drug Metab Dispos, 2008,36(8):1578.
14. Liu H, Yang J, Du F, et al. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats[J]. Drug Metab Dispos, 2009,37(12):2290.
15. Wu C Y, Benet L Z. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system [J]. Pharm Res, 2005,22(1):11.
16. Dahan A, Miller J, Amidon G. Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs[J]. AAPS J, 2009,11(4):740.
17. Chen M L, Yu L. The use of drug metabolism for prediction of intestinal permeability[J]. Mol Pharmaceut, 2009,6(1):74.
18. Benet L, Amidon G, Barends D, et al. The use of BDDCS in classifying the permeability of marketed drugs [J]. Pharm Res, 2008,25(3):483.
19. Han Y, Guo D, Chen Y. Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers [J]. Xenobiotica, 2009,39(9):694.
20. Jiang X, Blair E Y, McLachlan A J. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach [J]. J Clin Pharmacol, 2006,46(11):1370.